IFN-γ inhibits ILC2 proliferation and IL-13 expression in vivo and in vitro, thereby alleviating RV-induced mucous metaplasia, and its deficiency in the production in immature mice may lead to the development of asthma-like phenotypes after early RV infection (Han et al., 2017). The gene discussed is IL13; the disease is asthma.